NASDAQ: TRVI
Trevi Therapeutics Inc Stock Ownership - Who owns Trevi Therapeutics?

Insider buying vs selling

Have Trevi Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher GallettaController and Principal Accounting Officer2025-12-024,225$0.51
$2.16kBuy

1 of 1

TRVI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRVI insiders and whales buy or sell their stock.

TRVI Shareholders

What type of owners hold Trevi Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Forest Baskett15.98%22,694,708$305.47MInsider
Peter W. Sonsini12.19%17,308,374$232.97MInsider
Scott D. Sandell9.98%14,171,176$190.74MInsider
Ali Behbahani9.98%14,171,176$190.74MInsider
Carmen Chang9.98%14,171,176$190.74MInsider
Anthony A. Florence Jr.9.98%14,171,176$190.74MInsider
Mohamad Makhzoumi9.98%14,171,176$190.74MInsider
Paul Edward Walker9.98%14,171,176$190.74MInsider
Nea Management Company LLC9.31%13,222,228$177.97MInstitution
New Enterprise Associates 16 LP8.64%12,273,280$165.20MInsider

1 of 3

TRVI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRVI43.91%56.09%Net Buying
PHVS90.09%5.21%Net SellingNet Selling
NKTR52.01%47.99%Net SellingNet Selling
AUPH57.47%14.58%Net BuyingNet Buying
HRMY78.89%21.11%Net SellingNet Selling

Trevi Therapeutics Stock Ownership FAQ

Who owns Trevi Therapeutics?

Trevi Therapeutics (NASDAQ: TRVI) is owned by 95.04% institutional shareholders, 121.40% Trevi Therapeutics insiders, and 0.00% retail investors. Forest Baskett is the largest individual Trevi Therapeutics shareholder, owning 22.69M shares representing 15.98% of the company. Forest Baskett's Trevi Therapeutics shares are currently valued at $322.49M.

If you're new to stock investing, here's how to buy Trevi Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.